Vaccine adjuvants serve as the "force multipliers" of vaccines—enhancing immunogenicity, reducing the required antigen dosage, and extending the duration of protection—thereby directly determining a vaccine's overall efficacy.
For a long time, oil-emulsion adjuvants have been the absolute standard for livestock, poultry, and aquaculture vaccines. However, with the rise of large-scale farming operations and the rapid mutation of pathogens, the shortcomings of these traditional adjuvants have become increasingly apparent. In contrast, liposome and lipid nanoparticle (LNP) adjuvants—thanks to their advantages in safety, high efficiency, and broad compatibility—are emerging as the leading candidates to replace traditional oil-emulsion systems.
Today, drawing upon the latest research from 2026, we will use accessible language to explain: Why can liposome adjuvants replace oil-emulsion adjuvants? What concrete scientific evidence supports this? And what does the future hold for this technology?
Traditional Oil-Emulsion Adjuvants: Once the King, Now Plagued by Pain Points
Oil-emulsion adjuvants (such as the Montanide ISA series, Freund's adjuvant, and Emulsigen) are effective at inducing high antibody titers; however, in the context of modern farming practices and novel vaccines, their inherent flaws are becoming increasingly prominent:
1. Poor Safety Profile; Compromised Meat Quality
The mineral oil components within these adjuvants frequently trigger abscesses, granulomas, and tissue necrosis at the injection site. This severely degrades the carcass quality of meat-producing animals and also poses risks of inflammation and allergic reactions.
2. Imbalanced Immune Response
These adjuvants primarily induce a Th2-type humoral immune response, while providing only weak induction of cellular and mucosal immunity. Consequently, they offer insufficient protection against intracellular pathogens and mutated strains—such as those responsible for Foot-and-Mouth Disease (FMD), Classical Swine Fever, and influenza.
3. Weak Cross-Immunity Capabilities
As pathogens mutate at an accelerating pace, traditional oil-emulsion adjuvants struggle to induce broad-spectrum protection against these mutated strains.
4. Poor Stability; Stringent Storage and Transport Requirements
Exposure to high temperatures or freeze-thaw cycles can easily disrupt the emulsion, leading to phase separation. This places extremely strict demands on storage and transportation conditions.
5. Complex Manufacturing Processes; High Regulatory Compliance Risks
The emulsification process is cumbersome and prone to significant batch-to-batch variability. Furthermore, certain mineral oil components raise environmental and food safety concerns, thereby restricting their application in animals intended for human consumption. Simply put: oil-in-water emulsion adjuvants are effective, but they lack sufficient safety, versatility, and stability.
Liposomal Adjuvants: The New Generation of "Perfect Adjuvants"—Superiority That Outclasses Tradition
Liposomal adjuvants are composed of liposomes combined with immune enhancers (such as TLR agonists, CpG, and saponins); the synergy is such that 1+1 > 2, effectively doubling the immune response. Since liposomes consist primarily of phospholipids and cholesterol, their composition closely mimics that of cell membranes, ensuring exceptional biocompatibility. Compared to oil-in-water emulsion adjuvants, their advantages are comprehensively superior across the board:
1. Maximum Safety: No Residues, Minimal Irritation
They are biodegradable and leave no mineral oil residues, thereby preventing inflammation at the injection site and preserving the quality of meat products—making them the preferred choice for vaccines intended for food-producing animals.
2. A "Well-Rounded" Immune Response
They induce a balanced immune response involving Th1, Th2, and Th17 pathways. This approach not only elicits high-titer antibody production but also enhances cell-mediated immunity, making them more effective against intracellular pathogens and mutated viral strains.
3. Eliciting Stronger Cross-Immunity
Their cross-protective efficacy against mutated viral strains (such as highly mutable influenza viruses, Porcine Reproductive and Respiratory Syndrome Virus [PRRSV], and African Swine Fever Virus [ASFV]) is far superior to that of traditional adjuvants.
4. Excellent Stability and Injectability
They possess robust physical stability, facilitating easier storage and transportation. Furthermore, their low viscosity ensures excellent flow through injection needles, making them more convenient to administer.
In summary: greater safety, stronger efficacy, broader applicability, and greater ease of use.
Concrete Scientific Evidence: Multiple Studies Confirm the Superiority of Liposomal Adjuvants
Liposomal adjuvants are not merely a theoretical concept; numerous authoritative studies have already confirmed their superiority over traditional oil-in-water emulsion adjuvants:
-
1997 Influenza Vaccine Study: Vaccines utilizing a liposomal-saponin adjuvant were able to induce specific cytotoxic T-cell responses—an effect not observed with oil-in-water emulsion vaccines. Additionally, the liposomal-saponin adjuvant resulted in significantly less inflammation at the injection site.
-
1997 and 2003 Malaria Vaccine Studies: Liposomal adjuvant formulations (specifically RTS,S/AS01) demonstrated higher protective efficacy rates compared to oil-in-water emulsion formulations.
-
2021 Hepatitis B Vaccine Research: The frequency of CD4+ T cells induced by liposome adjuvants (AS01B/AS01E) was significantly higher than that induced by oil-in-water emulsion adjuvants (AS03) and aluminum adjuvants.
-
Latest 2026 HIV Vaccine Research: The quantity of CD4+ T cells and IgG antibody levels induced by the liposome adjuvant AS01B were significantly higher than those induced by the oil-in-water emulsion adjuvant MF59 and aluminum adjuvants.
These data conclusively demonstrate that liposome adjuvants comprehensively outperform oil-in-water emulsion adjuvants in terms of immunogenicity, cellular immunity, and safety.
Three Major Replacement Pathways: Simple Implementation, Rapid Upgrading
Replacing oil-in-water emulsion adjuvants with liposomes does not entail starting from scratch; rather, it represents a smooth transition and a rapid upgrade:
01 Direct Replacement
In inactivated vaccines, liposome adjuvants can directly replace oil-in-water emulsion adjuvants such as ISA 201/206. The manufacturing process and administration methods remain unchanged, allowing for a seamless upgrade.
02 Adaptation for Novel Vaccines
Novel vaccine types—such as DNA, mRNA, and recombinant subunit vaccines—are naturally compatible with liposome or lipid nanoparticle delivery systems, enabling the direct replacement of oil-in-water emulsion adjuvants.
03 Compound Optimization
Combining liposomes with low-toxicity vegetable oils allows for a synergistic approach that captures both the long-acting depot effect of oil-in-water emulsions and the superior safety profile of liposomes, resulting in enhanced immune efficacy and reduced antigen dosage requirements.
Conclusion and Outlook: Veterinary Vaccines Enter a "New Era of Balanced Immunity"
Extensive scientific evidence and clinical data indicate that liposome adjuvants now possess the capability to comprehensively replace traditional oil-in-water emulsion adjuvants.
While liposome adjuvants are already widely utilized in the field of human vaccines, the maturation of novel lipid materials and manufacturing processes is poised to establish them as the core adjuvants for the next generation of veterinary vaccines. This shift will drive the industry's evolution from a "humoral immunity-dominant" paradigm toward one of "balanced immune protection," providing safer, more efficient, and broader-spectrum solutions for the prevention and control of diseases in livestock, poultry, and aquaculture.
In the future, vaccines utilizing safer, more efficient, and highly compatible liposome adjuvants will emerge as the mainstream choice for disease prevention within the animal husbandry sector!
https://en.jicangbio.com/how-do-liposome-adjuvants-replace-traditional-oil-emulsion-adjuvants.html